中文名称:氯匹多瑞
- (2S)-2-(2-氯苯基)-2-(4,5,6,7-四氢噻吩[3,2-c]并吡啶-5-基)乙酸甲酯; 克拉匹多; 氯吡格雷碱; 氯吡格雷; 氯吡格雷游离碱; S(+)-2-(2-氯苯基)-2-(4,5,6,7-四氢噻吩[3,2-c]并吡啶-5)乙酸甲酯
- Clopidogrel
- methyl (2s)-2-(2-chlorophenyl)-2-(9-thia-4-azabicyclo[4.3.0]nona-7,10-dien-4-yl)acetate; ClopidogrelHydrobromide; ClopidogrelHydrogenSulfateBase; ClopidogrelHcl; Methyl (+)-(S)-α-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate; methyl (2S)-2-(2-chlorophenyl)-2-(9-thia-4-azabicyclo[4.3.0]nona-7,10- dien-4-yl)acetate; DivK1c_000787; KBio1_000787; KBio2_000545; KBio2_003113; KBio2_005681; KBio3_002431; KBioGR_000689; KBioSS_000545; Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine -5(4H)-acetate; NINDS_000787; SPBio_000463; Spectrum2_000512; Spectrum3_001606; Spectrum4_000175; Spectrum_000105; Thieno(3,2-c)pyridine-5(4H)-acetic acid, alpha-(2-chlorophenyl)-6,7-di hydro-methyl ester(S)-; methyl (2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate; methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate; methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate sulfate (1:1); (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoic acid; methyl (2-chlorophenyl){[2-(thiophen-2-yl)ethyl]amino}acetate; (+)-(S)-methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate; methyl (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
- 113665-84-2
- C16H18ClNO6S2
- 419.9002
- InChI=1/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2-,1,2,3,4)/t15-;/m0./s1
- 用作抗凝血药
化工网